Clinical Trial Applications - Approved: Filter, Search, and view applications
| # | Protocol No | Study Title | Investigator(s) & Site(s) | Date Approved | |
|---|---|---|---|---|---|
411. |
ECCT/18/03/01 | JiPime JiPrEP (HIVST Study) HIV self-testing to improve the efficiency of PrEP delivery. |
Principal Investigator(s) 1. Kenneth Kairu Ngure Site(s) in Kenya KEMRI-CCR PHRD (THIKA) |
16-05-2018 |
View |
412. |
ECCT/18/05/02 | KINGA Study Immunogenetic Modulators of Mucosal Protection from HIV-1: The Kinga Study |
Principal Investigator(s) 1. Nelly Rwamba Mugo Site(s) in Kenya KEMRI-CCR - Partners in Health Research & Development (PHRD) Thika Site. |
26-07-2018 |
View |
413. |
ECCT/18/04/03 | ShangRing vs. Mogen Clamp for EIMC Evaluation of the ShangRing vs. Mogen Clamp for Early Infant Male Circumcision in sub-Saharan Africa |
Principal Investigator(s) 1. Richard Lee 2. Mark Barone Site(s) in Kenya 1. Homa Bay Teaching and Referral Hospital (Homa Bay county) 2. Jaramogi Oginga Odinga Teaching and Referral Hospital (Kisumu county) |
10-12-2018 |
View |
414. |
ECCT/18/04/02 | Maternal Influenza Vaccine Study Impact of HIV Infection and Malaria Parasitemia on Immunogenicity of Inactivated Influenza Vaccine in Pregnant Women and on Mother-to-Child Vaccine-induced Antibody Transfer |
Principal Investigator(s) 1. Sandra S Chaves Site(s) in Kenya 1. Siaya County Referral Hospital (Siaya county) 2. Bondo Sub-County Hospital (Siaya county) |
04-06-2018 |
View |
415. |
ECCT/17/11/01 | MTN 034 MTN 034 A Phase 2a Crossover Trial Evaluating the Safety of and Adherence to a Vaginal Matrix Ring Containing Dapivirine and Oral Emtricitabine/Tenofovir Disoproxil Fumarate in an Adolescent and Young Adult Female Population |
Principal Investigator(s) 1. ESTHER MUMBI MAKANGA Site(s) in Kenya KISUMU CRS |
08-02-2018 |
View |
416. |
ECCT/17/10/01 | Neo-Fosfo Intravenous and Oral Fosfomycin in Hospitalised Neonates with Clinical Sepsis: an open-label safety and pharmacokinetics study |
Principal Investigator(s) 1. James A Berkley Site(s) in Kenya KEMRI-WTRP |
18-12-2017 |
View |
417. |
ECCT/18/01/01 | Mal 094 Efficacy, safety and immunogenicity study of GSK Biologicals’ candidate malaria vaccine (SB257049) evaluating schedules with or without fractional doses, early Dose 4 and yearly doses, in children 5-17 months of age. |
Principal Investigator(s) 1. Aaron Samuels 2. Simon Kariuki Site(s) in Kenya 1. Siaya County Referral hospital (Siaya county) 2. Ngiya Health Center (Siaya county) 3. Kogelo Health Center (Siaya county) 4. Tingwangi (Siaya county) 5. Mulaha (Siaya county) 6. Nyathengo (Siaya county) 7. Bal Olengo (Siaya county) |
06-03-2018 |
View |
418. |
ECCT/17/09/04 | A5354 A5354 Effect of Antiretroviral Treatment Initiated During Acute HIV-1 Infection on Measures of HIV-1 Persistence and on HIV-1-Specific Immune Responses |
Principal Investigator(s) 1. Brian Baker Site(s) in Kenya KISUMU CRS |
21-03-2018 |
View |
419. |
ECCT/17/09/01 | HPTN 084 HPTN 084: A Phase 3 Double Blind Safety and Efficacy Study of Long-Acting Injectable Cabotegravir Compared to Daily Oral TDF/FTC for Pre-Exposure Prophylaxis in HIV-Uninfected Women |
Principal Investigator(s) 1. Samuel Gurrion Ouma Site(s) in Kenya KISUMU CRS |
01-12-2017 |
View |
420. |
ECCT/17/08/09 | A trial to compare two new combinations of antimalarial drugs with the standard combination of antimalarial drugs in Kenyan children An open-label randomised trial to assess the therapeutic efficacy and tolerability of arterolane-piperaquine plus single low dose primaquine versus arterolane-piperaquine plus mefloquine and single low dose primaquine versus artemether-lumefantrine plus single low dose primaquine in the treatment of uncomplicated falciparum malaria in children in Kenya. |
Principal Investigator(s) 1. Philip Bejon Site(s) in Kenya 1. Kilifi County Hospital - Paediatric Out patient and Inpatient department (Kilifi county) 2. Pingilikani Dispensary (Kilifi county) |
04-01-2018 |
View |